Microbiology
-
An AAV-ie based Vaccine effectively protects against SARS-CoV-2 and Circulating Variants
This article has 7 authors:Reviewed by ScreenIT
-
An intranasal ASO therapeutic targeting SARS-CoV-2
This article has 23 authors:Reviewed by ScreenIT
-
SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020
This article has 8 authors:Reviewed by ScreenIT
-
Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation
This article has 12 authors:Reviewed by ScreenIT
-
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
This article has 27 authors:Reviewed by ScreenIT
-
Viability of MS2 and Phi6 Bacteriophages on Carpet and Dust
This article has 12 authors:Reviewed by ScreenIT
-
Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells
This article has 14 authors:Reviewed by ScreenIT
-
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
This article has 34 authors:Reviewed by ScreenIT
-
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
This article has 6 authors:This article has been curated by 1 group: -
Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the Calu-3 proteome
This article has 8 authors:Reviewed by ScreenIT